Skip Page Header

Home > Opioid antagonists with minimal sedation for opioid withdrawal.

Gowing, Linda and Ali, Robert and White, Jason M [The Cochrane Library] . (2017) Opioid antagonists with minimal sedation for opioid withdrawal. John Wiley & Sons, Ltd. Cochrane Database of Systematic Reviews (6) DOI: 10.1002/14651858.CD002021.pub4

URL: http://onlinelibrary.wiley.com/doi/10.1002/1465185...

Key results:
We are uncertain whether peak withdrawal induced by opioid antagonists plus clonidine or lofexidine is more severe than withdrawal managed with clonidine or lofexidine alone, or whether the average severity over the withdrawal period is less, as the certainty of the evidence is very low.

Clinicians should warn people of the possibility of delirium in the first day of administration of naltrexone, particularly with higher doses (> 25 mg). People should also know that withdrawal will be moderately severe and that symptoms such as muscle aches, vomiting and diarrhoea, and insomnia are likely to persist despite medication.


Repository Staff Only: item control page